Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS) Stock Competitors & Peer Comparison
See (HIMS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HIMS | $30.56 | +8.56% | 6.7B | 59.90 | $0.51 | N/A |
| SIRO | $109.97 | +0.00% | 22B | N/A | N/A | N/A |
| NVST | $26.80 | -0.89% | 4.4B | 95.68 | $0.28 | N/A |
| CON | $22.82 | -0.78% | 2.9B | 17.55 | $1.30 | +1.09% |
| BBNX | $11.17 | -2.27% | 497.8M | -8.15 | -$1.37 | N/A |
| CV | $6.07 | +5.20% | 302.5M | -5.89 | -$1.03 | N/A |
| NAKA | $0.22 | -4.78% | 80.9M | -0.83 | -$0.26 | N/A |
| KDLY | $11.30 | +1.16% | 68.1M | -15.48 | -$0.73 | N/A |
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
| PARK | $17.95 | -0.83% | 35.1M | -100.17 | -$0.18 | N/A |
Stock Comparison
HIMS vs SIRO Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, HIMS is priced at $30.56, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas SIRO's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, HIMS is more volatile compared to SIRO. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check SIRO's competition here
HIMS vs NVST Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, NVST has a market cap of 4.4B. Regarding current trading prices, HIMS is priced at $30.56, while NVST trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas NVST's P/E ratio is 95.68. In terms of profitability, HIMS's ROE is +0.23%, compared to NVST's ROE of +0.02%. Regarding short-term risk, HIMS is more volatile compared to NVST. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check NVST's competition here
HIMS vs CON Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, CON has a market cap of 2.9B. Regarding current trading prices, HIMS is priced at $30.56, while CON trades at $22.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas CON's P/E ratio is 17.55. In terms of profitability, HIMS's ROE is +0.23%, compared to CON's ROE of +0.47%. Regarding short-term risk, HIMS is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check CON's competition here
HIMS vs BBNX Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, BBNX has a market cap of 497.8M. Regarding current trading prices, HIMS is priced at $30.56, while BBNX trades at $11.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas BBNX's P/E ratio is -8.15. In terms of profitability, HIMS's ROE is +0.23%, compared to BBNX's ROE of -0.23%. Regarding short-term risk, HIMS is more volatile compared to BBNX. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check BBNX's competition here
HIMS vs CV Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, CV has a market cap of 302.5M. Regarding current trading prices, HIMS is priced at $30.56, while CV trades at $6.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas CV's P/E ratio is -5.89. In terms of profitability, HIMS's ROE is +0.23%, compared to CV's ROE of +1.05%. Regarding short-term risk, HIMS is more volatile compared to CV. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check CV's competition here
HIMS vs NAKA Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, NAKA has a market cap of 80.9M. Regarding current trading prices, HIMS is priced at $30.56, while NAKA trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas NAKA's P/E ratio is -0.83. In terms of profitability, HIMS's ROE is +0.23%, compared to NAKA's ROE of -0.21%. Regarding short-term risk, HIMS is more volatile compared to NAKA. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check NAKA's competition here
HIMS vs KDLY Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, HIMS is priced at $30.56, while KDLY trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas KDLY's P/E ratio is -15.48. In terms of profitability, HIMS's ROE is +0.23%, compared to KDLY's ROE of -0.21%. Regarding short-term risk, HIMS is more volatile compared to KDLY. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check KDLY's competition here
HIMS vs NEUE Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, HIMS is priced at $30.56, while NEUE trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas NEUE's P/E ratio is -0.38. In terms of profitability, HIMS's ROE is +0.23%, compared to NEUE's ROE of +0.09%. Regarding short-term risk, HIMS is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check NEUE's competition here
HIMS vs PARK Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, PARK has a market cap of 35.1M. Regarding current trading prices, HIMS is priced at $30.56, while PARK trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas PARK's P/E ratio is -100.17. In terms of profitability, HIMS's ROE is +0.23%, compared to PARK's ROE of -67.96%. Regarding short-term risk, HIMS is more volatile compared to PARK. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check PARK's competition here
HIMS vs BRK Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, BRK has a market cap of 11.6M. Regarding current trading prices, HIMS is priced at $30.56, while BRK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas BRK's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to BRK's ROE of N/A. Regarding short-term risk, HIMS is more volatile compared to BRK. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check BRK's competition here
HIMS vs PFSA Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, PFSA has a market cap of 321.3K. Regarding current trading prices, HIMS is priced at $30.56, while PFSA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas PFSA's P/E ratio is -0.01. In terms of profitability, HIMS's ROE is +0.23%, compared to PFSA's ROE of +0.82%. Regarding short-term risk, HIMS is less volatile compared to PFSA. This indicates potentially lower risk in terms of short-term price fluctuations for HIMS.Check PFSA's competition here
HIMS vs DSCI Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, DSCI has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while DSCI trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas DSCI's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to DSCI's ROE of -0.00%. Regarding short-term risk, HIMS is more volatile compared to DSCI. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check DSCI's competition here
HIMS vs LPNT Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, LPNT has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while LPNT trades at $64.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas LPNT's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to LPNT's ROE of +0.05%. Regarding short-term risk, HIMS is more volatile compared to LPNT. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check LPNT's competition here
HIMS vs AMSG Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, AMSG has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while AMSG trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas AMSG's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to AMSG's ROE of +0.08%. Regarding short-term risk, HIMS is more volatile compared to AMSG. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check AMSG's competition here
HIMS vs ABAX Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, ABAX has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while ABAX trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas ABAX's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to ABAX's ROE of +0.10%. Regarding short-term risk, HIMS is more volatile compared to ABAX. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check ABAX's competition here
HIMS vs MEDC Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, MEDC has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas MEDC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to MEDC's ROE of N/A. Regarding short-term risk, HIMS is less volatile compared to MEDC. This indicates potentially lower risk in terms of short-term price fluctuations for HIMS.Check MEDC's competition here
HIMS vs COTV Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, COTV has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while COTV trades at $44.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas COTV's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to COTV's ROE of +0.14%. Regarding short-term risk, HIMS is more volatile compared to COTV. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check COTV's competition here
HIMS vs EVHC Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, EVHC has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while EVHC trades at $45.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas EVHC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to EVHC's ROE of +0.07%. Regarding short-term risk, HIMS is more volatile compared to EVHC. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check EVHC's competition here
HIMS vs CYNO Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, CYNO has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while CYNO trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas CYNO's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to CYNO's ROE of +0.03%. Regarding short-term risk, HIMS is more volatile compared to CYNO. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check CYNO's competition here
HIMS vs SPAN Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, SPAN has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while SPAN trades at $29.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas SPAN's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, HIMS is more volatile compared to SPAN. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check SPAN's competition here
HIMS vs EXAC Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, EXAC has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas EXAC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, HIMS is more volatile compared to EXAC. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check EXAC's competition here
HIMS vs SCAI Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, SCAI has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while SCAI trades at $55.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas SCAI's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to SCAI's ROE of +0.09%. Regarding short-term risk, HIMS is more volatile compared to SCAI. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check SCAI's competition here
HIMS vs LDR Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, LDR has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while LDR trades at $67.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas LDR's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to LDR's ROE of +1.17%. Regarding short-term risk, HIMS is more volatile compared to LDR. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check LDR's competition here
HIMS vs ABCO Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, ABCO has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while ABCO trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas ABCO's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to ABCO's ROE of +0.19%. Regarding short-term risk, HIMS is more volatile compared to ABCO. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check ABCO's competition here
HIMS vs SPNC Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, SPNC has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while SPNC trades at $38.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas SPNC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to SPNC's ROE of -0.61%. Regarding short-term risk, HIMS is more volatile compared to SPNC. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check SPNC's competition here
HIMS vs MZOR Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, MZOR has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while MZOR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas MZOR's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to MZOR's ROE of -0.14%. Regarding short-term risk, HIMS is more volatile compared to MZOR. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check MZOR's competition here
HIMS vs PMC Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, PMC has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while PMC trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas PMC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to PMC's ROE of +0.04%. Regarding short-term risk, HIMS is more volatile compared to PMC. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check PMC's competition here
HIMS vs STJ Comparison April 2026
HIMS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.7B. In comparison, STJ has a market cap of 0. Regarding current trading prices, HIMS is priced at $30.56, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of 59.90, whereas STJ's P/E ratio is N/A. In terms of profitability, HIMS's ROE is +0.23%, compared to STJ's ROE of +0.21%. Regarding short-term risk, HIMS is more volatile compared to STJ. This indicates potentially higher risk in terms of short-term price fluctuations for HIMS.Check STJ's competition here